204 related articles for article (PubMed ID: 32966799)
1. 11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma.
Siaw JT; Javanmardi N; Van den Eynden J; Lind DE; Fransson S; Martinez-Monleon A; Djos A; Sjöberg RM; Östensson M; Carén H; Trøen G; Beiske K; Berbegall AP; Noguera R; Lai WY; Kogner P; Palmer RH; Hallberg B; Martinsson T
Cell Rep; 2020 Sep; 32(12):108171. PubMed ID: 32966799
[TBL] [Abstract][Full Text] [Related]
2. Low DLG2 gene expression, a link between 11q-deleted and MYCN-amplified neuroblastoma, causes forced cell cycle progression, and predicts poor patient survival.
Keane S; Améen S; Lindlöf A; Ejeskär K
Cell Commun Signal; 2020 Apr; 18(1):65. PubMed ID: 32312269
[TBL] [Abstract][Full Text] [Related]
3. DLG2 impairs dsDNA break repair and maintains genome integrity in neuroblastoma.
Keane S; de Weerd HA; Ejeskär K
DNA Repair (Amst); 2022 Apr; 112():103302. PubMed ID: 35217496
[TBL] [Abstract][Full Text] [Related]
4. Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis.
Lopez-Delisle L; Pierre-Eugène C; Louis-Brennetot C; Surdez D; Raynal V; Baulande S; Boeva V; Grossetête-Lalami S; Combaret V; Peuchmaur M; Delattre O; Janoueix-Lerosey I
Oncogene; 2018 Mar; 37(11):1417-1429. PubMed ID: 29321660
[TBL] [Abstract][Full Text] [Related]
5. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
Higashi M; Kolla V; Iyer R; Naraparaju K; Zhuang T; Kolla S; Brodeur GM
Mol Cancer; 2015 Aug; 14():150. PubMed ID: 26245651
[TBL] [Abstract][Full Text] [Related]
7. Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR-942-5p and releasing DLG2 via Hippo-YAP signaling.
Li S; Yan G; Liu W; Li C; Wang X
Mol Carcinog; 2020 Dec; 59(12):1323-1342. PubMed ID: 33128289
[TBL] [Abstract][Full Text] [Related]
8. The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development.
Higashi M; Sakai K; Fumino S; Aoi S; Furukawa T; Tajiri T
Surg Today; 2019 Sep; 49(9):721-727. PubMed ID: 30848386
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
Schönherr C; Ruuth K; Kamaraj S; Wang CL; Yang HL; Combaret V; Djos A; Martinsson T; Christensen JG; Palmer RH; Hallberg B
Oncogene; 2012 Dec; 31(50):5193-200. PubMed ID: 22286764
[TBL] [Abstract][Full Text] [Related]
10. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional repressor SNAI2 impairs neuroblastoma differentiation and inhibits response to retinoic acid therapy.
Vrenken KS; Vervoort BMT; van Ingen Schenau DS; Derks YHW; van Emst L; Grytsenko PG; Middelbeek JAJ; van Leeuwen FN
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165644. PubMed ID: 31862304
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.
Zhuang RJ; Bai XX; Liu W
Cancer Biol Ther; 2019; 20(6):897-911. PubMed ID: 30862230
[TBL] [Abstract][Full Text] [Related]
13. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.
Nair PN; McArdle L; Cornell J; Cohn SL; Stallings RL
Cancer Genet Cytogenet; 2007 Apr; 174(2):100-10. PubMed ID: 17452250
[TBL] [Abstract][Full Text] [Related]
14. Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q.
Fischer M; Bauer T; Oberthür A; Hero B; Theissen J; Ehrich M; Spitz R; Eils R; Westermann F; Brors B; König R; Berthold F
Oncogene; 2010 Feb; 29(6):865-75. PubMed ID: 19901960
[TBL] [Abstract][Full Text] [Related]
15. Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer.
Wulf AM; Moreno MM; Paka C; Rampasekova A; Liu KJ
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769149
[TBL] [Abstract][Full Text] [Related]
16. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
17. Lamin A/C Is Required for ChAT-Dependent Neuroblastoma Differentiation.
Guglielmi L; Nardella M; Musa C; Iannetti I; Arisi I; D'Onofrio M; Storti A; Valentini A; Cacci E; Biagioni S; Augusti-Tocco G; D'Agnano I; Felsani A
Mol Neurobiol; 2017 Jul; 54(5):3729-3744. PubMed ID: 27221609
[TBL] [Abstract][Full Text] [Related]
18. The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness.
Mus LM; Lambertz I; Claeys S; Kumps C; Van Loocke W; Van Neste C; Umapathy G; Vaapil M; Bartenhagen C; Laureys G; De Wever O; Bexell D; Fischer M; Hallberg B; Schulte J; De Wilde B; Durinck K; Denecker G; De Preter K; Speleman F
Sci Rep; 2020 Jan; 10(1):218. PubMed ID: 31937834
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of hASH1 is associated with the retinoic acid-induced differentiation of human neuroblastoma cell lines.
Ichimiya S; Nimura Y; Seki N; Ozaki T; Nagase T; Nakagawara A
Med Pediatr Oncol; 2001 Jan; 36(1):132-4. PubMed ID: 11464865
[TBL] [Abstract][Full Text] [Related]
20. Sub-micromolar concentrations of retinoic acid induce morphological and functional neuronal phenotypes in SK-N-SH neuroblastoma cells.
Harasym E; McAndrew N; Gomez G
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):798-809. PubMed ID: 28840512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]